Jonathan Lischalk, MD

Disclosure information not submitted.

Presentation(s):

• PD22-10: High volume biopsy core involvement predicts for elevated PSA nadir following definitive SBRT in intermediate risk prostate cancer

  Saturday, May 14, 2022
  11:00 AM – 11:10 AM